Business development & licensing services

Business development & licensing services
Product Description

HOT DOSSIERS: Atorvastatin + Ezetimibe tabs, Lenalidomide caps, Levodropropizine syrup

Midas Pharma Polska Sp. z.o.o. offers company's Own as well as Third Party Dossiers, co-development & contract development. 

BD&L services include commercialization strategy, promotion, search strategy and scouting, shortlisting and feasibility checking, negotiation, transaction support, etc.

Read more Show less

Midas Pharma Polska Sp. z.o.o.

  • Country/Region:
    Poland
  • On CPHI since:
    2015
Company types
Contract Service
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Experienced Technicians; Quality Service; Reputation
  • Supplied from
    Poland
More specifications Fewer specifications
Sales Markets
Show more Show less

Midas Pharma Polska Sp. z.o.o.

  • Country/Region:
    Poland
  • On CPHI since:
    2015
Company types
Contract Service
View company profile

More Products from Midas Pharma Polska Sp. z.o.o. (2)

  • Active Pharmaceutical Ingredients & Intermediates

    Product Active Pharmaceutical Ingredients & Intermediates

    API & IM businesses are belonging to the core areas of Midas Pharma Polska Sp. z o.o. activities. Besides the Third Party products we offer Midas' own APIs like: Warfarin Sodium (CEP), Ketoprofen (CEP in progress), Doxapram HCl, Doxazosin Maleate, Trospium Chloride, A...
  • Finished product development services

    Product Finished product development services

    NEWS: Hot Melt Extruction is the newest technology now available at Midas Pharma.
    Midas Pharma Polska Sp. z.o.o. provides a complete range of services for developing and manufacturing finished drug products, and we have expertise and experience to overcome challenging galenical or analytical hurdles. It...